BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35716259)

  • 21. Long non-coding RNA F11-AS1 inhibits HBV-related hepatocellular carcinoma progression by regulating NR1I3 via binding to microRNA-211-5p.
    Deng Y; Wei Z; Huang M; Xu G; Wei W; Peng B; Nong S; Qin H
    J Cell Mol Med; 2020 Jan; 24(2):1848-1865. PubMed ID: 31880390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HBx Protein Contributes to Liver Carcinogenesis by H3K4me3 Modification Through Stabilizing WD Repeat Domain 5 Protein.
    Gao W; Jia Z; Tian Y; Yang P; Sun H; Wang C; Ding Y; Zhang M; Zhang Y; Yang D; Tian Z; Zhou J; Ruan Z; Wu Y; Ni B
    Hepatology; 2020 May; 71(5):1678-1695. PubMed ID: 31544250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B virus X protein-induced SH2 domain-containing 5 (SH2D5) expression promotes hepatoma cell growth via an SH2D5-transketolase interaction.
    Zheng Y; Ming P; Zhu C; Si Y; Xu S; Chen A; Wang J; Zhang B
    J Biol Chem; 2019 Mar; 294(13):4815-4827. PubMed ID: 30659097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stabilization of E2-EPF UCP protein is implicated in hepatitis B virus-associated hepatocellular carcinoma progression.
    Lim JH; Kim DG; Yu DY; Kang HM; Noh KH; Kim DS; Park D; Chang TK; Im DS; Jung CR
    Cell Mol Life Sci; 2019 Jul; 76(13):2647-2662. PubMed ID: 30903204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HBX suppresses PTEN to promote the malignant progression of hepatocellular carcinoma through mi-R155 activation.
    Niu LJ; Huang T; Wang L; Sun XF; Zhang YM
    Ann Hepatol; 2022; 27(3):100688. PubMed ID: 35196550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro.
    Salpini R; Surdo M; Cortese MF; Palumbo GA; Carioti L; Cappiello G; Spanò A; Trimoulet P; Fleury H; Vecchiet J; Pasquazzi C; Mirabelli C; Scutari R; Sacco A; Alkhatib M; Missale G; Francioso S; Sarmati L; Andreoni M; Angelico M; Ceccherini-Silberstein F; Levrero M; Perno CF; Belloni L; Svicher V
    Clin Microbiol Infect; 2019 Jul; 25(7):906.e1-906.e7. PubMed ID: 30472417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell cycle-related kinase mediates viral-host signalling to promote hepatitis B virus-associated hepatocarcinogenesis.
    Yu Z; Gao YQ; Feng H; Lee YY; Li MS; Tian Y; Go MY; Yu DY; Cheung YS; Lai PB; Yu J; Wong VW; Sung JJ; Chan HL; Cheng AS
    Gut; 2014 Nov; 63(11):1793-804. PubMed ID: 24440987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RPS3a over-expressed in HBV-associated hepatocellular carcinoma enhances the HBx-induced NF-κB signaling via its novel chaperoning function.
    Lim KH; Kim KH; Choi SI; Park ES; Park SH; Ryu K; Park YK; Kwon SY; Yang SI; Lee HC; Sung IK; Seong BL
    PLoS One; 2011; 6(8):e22258. PubMed ID: 21857917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel mutant 10Ala/Arg together with mutant 144Ser/Arg of hepatitis B virus X protein involved in hepatitis B virus-related hepatocarcinogenesis in HepG2 cell lines.
    Shi Y; Wang J; Wang Y; Wang A; Guo H; Wei F; Mehta SR; Espitia S; Smith DM; Liu L; Zhang Y; Chen D
    Cancer Lett; 2016 Feb; 371(2):285-91. PubMed ID: 26706415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18.
    Du Y; Kong G; You X; Zhang S; Zhang T; Gao Y; Ye L; Zhang X
    J Biol Chem; 2012 Jul; 287(31):26302-11. PubMed ID: 22685290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis B virus X protein boosts hepatocellular carcinoma progression by downregulating microRNA-137.
    Gao Y; Gu J; Wang Y; Fu D; Zhang W; Zheng G; Wang X
    Pathol Res Pract; 2020 Jun; 216(6):152981. PubMed ID: 32527447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
    Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
    J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis B virus, HBx mutants and their role in hepatocellular carcinoma.
    Ali A; Abdel-Hafiz H; Suhail M; Al-Mars A; Zakaria MK; Fatima K; Ahmad S; Azhar E; Chaudhary A; Qadri I
    World J Gastroenterol; 2014 Aug; 20(30):10238-48. PubMed ID: 25132741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B virus X protein (HBx)-related long noncoding RNA (lncRNA) down-regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin.
    Huang JF; Guo YJ; Zhao CX; Yuan SX; Wang Y; Tang GN; Zhou WP; Sun SH
    Hepatology; 2013 May; 57(5):1882-92. PubMed ID: 23239537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of MicroRNA-145 Caused by Hepatitis B Virus X Protein Promotes Expression of CUL5 and Contributes to Pathogenesis of Hepatitis B Virus-Associated Hepatocellular Carcinoma.
    Gao F; Sun X; Wang L; Tang S; Yan C
    Cell Physiol Biochem; 2015; 37(4):1547-59. PubMed ID: 26512974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. c-Jun N-terminal kinase inhibitor favors transforming growth factor-β to antagonize hepatitis B virus X protein-induced cell growth promotion in hepatocellular carcinoma.
    Wu YH; Ai X; Liu FY; Liang HF; Zhang BX; Chen XP
    Mol Med Rep; 2016 Feb; 13(2):1345-52. PubMed ID: 26648552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hedgehog signaling blockade delays hepatocarcinogenesis induced by hepatitis B virus X protein.
    Arzumanyan A; Sambandam V; Clayton MM; Choi SS; Xie G; Diehl AM; Yu DY; Feitelson MA
    Cancer Res; 2012 Nov; 72(22):5912-20. PubMed ID: 22986746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HBx promotes hepatocarcinogenesis by enhancing phosphorylation and blocking ubiquitinylation of UHRF2.
    Cheng F; Qian G; Fang X; Sun J; Chen S; Chen R; Liu S; Li Z; Wu K; Jiang S; Chen Y; Tang N; Chen J; Duan C
    Hepatol Int; 2021 Jun; 15(3):707-719. PubMed ID: 33876395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis B virus X protein promotes MAN1B1 expression by enhancing stability of GRP78 via TRIM25 to facilitate hepatocarcinogenesis.
    You H; Zhang N; Yu T; Ma L; Li Q; Wang X; Yuan D; Kong D; Liu X; Hu W; Liu D; Kong F; Zheng K; Tang R
    Br J Cancer; 2023 Apr; 128(6):992-1004. PubMed ID: 36635499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B virus whole-X and X protein play distinct roles in HBV-related hepatocellular carcinoma progression.
    Zhang Y; Liu H; Yi R; Yan T; He Y; Zhao Y; Liu J
    J Exp Clin Cancer Res; 2016 Jun; 35(1):87. PubMed ID: 27255760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.